2,449 results on '"Colombo, Massimo"'
Search Results
2. Venture capital and the delegation of decision authority in startups: an exploratory study
3. Emergence of new firms: A test of the resource-based view, signaling and behavioral perspectives
4. An atlas of the human liver diurnal transcriptome and its perturbation by hepatitis C virus infection
5. Open innovation, value creation and value capture : an introduction
6. Real-world evidence on non-invasive tests and associated cut-offs used to assess fibrosis in routine clinical practice
7. Treatment of experienced and naïve patients with hepatitis C : focus on telaprevir
8. What drives the valuation of entrepreneurial ventures? A map to navigate the literature and research directions
9. The management of liver disease in people with congenital bleeding disorders: guidance from European Association for Haemophilia and Allied Disorders, European Haemophilia Consortium, ISTH, and World Federation of Hemophilia
10. A Real‐World Observational Cohort of Patients with Hepatocellular Carcinoma: Design and Rationale for TARGET‐HCC
11. A global research priority agenda to advance public health responses to fatty liver disease
12. Radial and longitudinal margins in surgery of perihilar cholangiocarcinoma: When R1 definition is associated with different prognosis
13. The exposome and liver disease - how environmental factors affect liver health
14. The dark side of signals: Patents protecting radical inventions and venture capital investments
15. The long-term effects of loan guarantees on SME performance
16. OS-061 Chronic hepatitis C virus infection induces HCC risk by perturbing the human liver circadian transcriptome and epigenome through deregulation of the deacetylase SIRT1
17. (Co, Ni)Sn0.5 nanoparticles supported on hierarchical CN-graphene-based electrocatalysts for the oxygen reduction reaction
18. Dancing with Strangers? Initial Trust and the Formation of Initial Ties Between New Ventures and Corporate Venture Capitalists.
19. Natural History of Hepatitis C Infection
20. Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease
21. Long-term Patient-Centered Outcomes in Cirrhotic Patients With Chronic Hepatitis C After Achieving Sustained Virologic Response
22. The “first match” between high-tech entrepreneurial ventures and universities: the role of founders’ social ties
23. Dynamic capabilities and high-tech entrepreneurial ventures’ performance in the aftermath of an environmental jolt
24. What drives the delegation of innovation decisions? The roles of firm innovation strategy and the nature of external knowledge
25. Receiving external equity following successfully crowdfunded technological projects: an informational mechanism
26. EVALUATION OF PREDICTORS OF INEFFECTIVENESS OF ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS C IN THE REPUBLIC OF KAZAKHSTAN: A MATCHED CASECONTROL STUDY.
27. Cultural distance and the permanence of acquired CEOs in cross-border hightech acquisitions: combining the acquirer’s and CEO’s perspectives.
28. Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials
29. Start-ups launched by recent STEM university graduates: The impact of university education on entrepreneurial entry
30. Elimination of hepatitis C in Europe: can WHO targets be achieved?
31. Dancing With Strangers? Initial Trust and the Formation of Initial Ties Between New Ventures and Corporate Venture Capitalists
32. Evaluation of Predictors of Ineffectiveness of Antiviral Therapy for Chronic Hepatitis C in the Republic of Kazakhstan
33. Knowledge misappropriation risks and contractual complexity in entrepreneurial ventures’ non-equity alliances
34. The governance of entrepreneurial ecosystems
35. Intrahepatic cholangiocellular carcinoma with radiological enhancement patterns mimicking hepatocellular carcinoma
36. Crowdfunding for Entrepreneurs
37. EASL Clinical Practice Guideline: Occupational liver diseases
38. Hepatotoxicity of immune check point inhibitors: Approach and management
39. Design of catalytically active porous gold structures from a bottom-up method: The role of metal traces in CO oxidation and oxidative coupling of methanol
40. Feasibility and reproducibility of liver and pancreatic stiffness in patients with alcohol-related liver disease
41. The geography of venture capital and entrepreneurial ventures’ demand for external equity
42. Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial
43. Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection
44. Green oriented crowdfunding campaigns: Their characteristics and diffusion in different institutional settings
45. Contrast imaging techniques to diagnose hepatocellular carcinoma in cirrhotics outside regular surveillance
46. Predictors of hepatocellular carcinoma in HCV cirrhotic patients treated with direct acting antivirals
47. Signaling in science-based IPOs: The combined effect of affiliation with prestigious universities, underwriters, and venture capitalists
48. Metal-support interaction in catalysis: The influence of the morphology of a nano-oxide domain on catalytic activity
49. Cultural distance and the permanence of acquired CEOs in cross‐border high‐tech acquisitions: combining the acquirer's and CEO's perspectives
50. Hepatocellular Carcinoma Prevention in the Era of Hepatitis C Elimination
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.